Tylvalosin

Star0

DB11554ExperimentalVet approvedSmall molecule

Tylvalosin: Overview.

Formula / weight: C₅₃H₈₇NO₁₉ · 1042.267 g/mol (avg)

Resolves to

Compound

UNII9T02S42WQOCAS63409-12-1ChEMBLCHEMBL2103834

Clinical / RWD

RxNorm1368469

Structure

InChIKeyKCJJINQANFZSAM-HZDSEHBESA-NSMILES

CC[C@H]1OC(=O)C[C@@H](OC(C)=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H](CC=O)C[C@@H](C)C(=O)\C=C\C(\C)=C\[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC

Targets

P09598plc

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

174Drug interactionsStructured to mechanism, not free text

1Marketed productAcross 1 country and 1 labeller

11+ReferencesStructured and connected to the statements they support

Which drugs share a target with Tylvalosin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account